Trial intelligence / Profile preview

Selenium Supplementation in Subarachnoid Haemorrhage Patients

2005-004684-31Phase 2Completed

Sponsor
Barts Health NHS Trust
Start
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of sodium selenite in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Barts Health NHS Trust. Primary endpoint: Plasma selenium levels. Started Jan 2006; status: completed.

02

Drugs

sodium selenite
03

Conditions

subarachnoid hemorrhage (SAH)

Beyond the preview

Go deeper on 2005-004684-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004684-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call